Dr. Lal PathLabs has informed that it attached a copy of Company's Q1 FY23 Earnings Presentation, which the Company proposes to share with Analysts/ Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2022, approved by the Board of Directors in their meeting held on July 28, 2022.
The above information is a part of company’s filings submitted to BSE.